PCM
GWPH

Portolan Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Portolan Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-47,091
Closed -$4.58M – 198
2020
Q3 		$4.58M Buy
47,091
+2,714
+6% +$312K 0.52% 81
2020
Q2 		$5.45M Buy
44,377
+2,967
+7% +$337K 0.62% 63
2020
Q1 		$3.63M Buy
+41,410
New +$4.39M 0.54% 63

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Portolan Capital Management's GWPH Position: Q4 2020 in Review

Portolan Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 47,091 shares — an estimated $4.58M sold.

Portolan Capital Management first reported a position in GWPH in Q1 2020 and held it in 3 quarters. The position peaked at $5.45M in Q2 2020. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

  • Portolan Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Portolan Capital Management sold 47,091 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $4.58M.
  • Portolan Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2020 and held it in 3 quarters.
  • Portolan Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5.45M in Q2 2020.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Portolan Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.